Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis

Journal of Cataract and Refractive Surgery

Volumn 34, Issue 6, 2008, Pages 963-967

  Lee, Ji Hoon ^a   You, Yong Sung ^a   Choe, Chul Myong ^a   Lee, Eun Suk ^a  

^a NUNE Eye Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRIMONIDINE; EYE DROPS;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; EVALUATION; HALOS; HUMAN; KERATOMILEUSIS; KOREA; LIGHT; LUMINANCE; MEASUREMENT; NIGHT VISION; PRIORITY JOURNAL; PUPIL; PUPILLOMETER; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; VISUAL DISORDER;

ADRENERGIC ALPHA-AGONISTS; ADULT; FEMALE; HUMANS; KERATOMILEUSIS, LASER IN SITU; LASERS, EXCIMER; LIGHT; MALE; NIGHT BLINDNESS; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PUPIL; QUINOXALINES; TREATMENT OUTCOME;

EID: 43849092648     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2008.01.028     Document Type: Article

References (14)

1. Schallhorn S.C., Kaupp S.E., Tanzer D.J., Tidwell J., Laurent J., and Bourque L.B. Pupil size and quality of vision after LASIK. Ophthalmology 110 (2003) 1606-1614
2. Katz L.J. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients; the Brimonidine Study Group. Am J Ophthalmol 127 (1999) 20-26
3. Barnebey H.S., Robin A.L., Zimmerman T.J., Morrison J.C., Hersh S.B., Lewis R.A., Coleman A.L., Cinotti D.J., Walt J., Chen K.S., and Kelley E.P. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty. Ophthalmology 100 (1993) 1083-1088
4. Chevrier R.L., Assalian A., Duperré J., and Lesk M.R. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation after anterior segment laser procedures. Ophthalmic Surg Laser 30 (1999) 199-204
5. Fan-Paul N.I., Li J., Sullivan Miller J., and Florakis G.J. Night vision disturbances after corneal refractive surgery. Surv Ophthalmol 47 (2002) 533-546
6. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
7. Randazzo A., Nizzola F., Rossetti L., Orzalesi N., and Vinciguerra P. Pharmacological management of night vision disturbances after refractive surgery; results of a randomized clinical trial. J Cataract Refract Surg 31 (2005) 1764-1772
8. Kesler A., Shemesh G., Rothkoff L., and Lazar M. Effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size. J Cataract Refract Surg 30 (2004) 1707-1710
9. McDonald II J.E., El-Moatassem Kotb A.M., and Decker B.B. Effect of brimonidine tartrate ophthalmic solution 0.2% on pupil size in normal eyes under different luminance conditions. J Cataract Refract Surg 27 (2001) 560-564
10. Marx-Gross S., Krummenauer F., Dick H.B., and Pfeiffer N. Brimonidine versus dapiprazole: influence on pupil size at various illumination levels. J Cataract Refract Surg 31 (2005) 1372-1376
11. Altman D.G. Practical Statistics for Medical Research (1991), Chapman and Hall, London, UK 211-212
12. Boxer Wachler B.S., Hiatt D., Chou B., and Christie J.P. Reduction of pupil size and halos with minus lenses after laser in situ keratomileusis. J Refract Surg 20 (2004) 149-154
13. Pieh S., Lackner B., Hanselmayer G., Zöhrer R., Sticker M., Weghaupt H., Fercher A., and Skorpik C. Halo size under distance and near conditions in refractive multifocal intraocular lenses. Br J Ophthalmol 85 (2001) 816-821
14. Lackner B., Pieh S., Schmidinger G., Hanselmayer G., Simader C., Reitner A., and Skorpik C. Glare and halo phenomena after laser in situ keratomileusis. J Cataract Refract Surg 29 (2003) 444-450